INS and Glucose intolerance: Wei Chen et al. found that TXX-522 and rimonabant both reduced fasting blood glucose and insulin levels in male Sprague-Dawley rats but that TXX-522 improved glucose intolerance more than rimonabant at the same dose, which was shown by oral glucose tolerance testing.